A blog by Ronny Allan

Detectnet™ (64Cu-DOTATATE) – an expansion of the Somatostatin Receptor PET Imaging for Neuroendocrine Cancer

Detectnet™ (64Cu-DOTATATE) – an expansion of the Somatostatin Receptor PET Imaging for Neuroendocrine Cancer

Updated Jan 2026

What is 64CU dotatate

It’s a high‑resolution PET tracer for imaging somatostatin‑receptor–positive neuroendocrine tumours (NETs), offering better lesion detection, longer imaging windows, and lower positron energy than 68Ga‑labelled agents. It consistently produces high tumour‑to‑background contrast and often finds additional metastatic sites missed by older SPECT agents like 111In‑octreotide.

🧬 64Cu‑DOTATATE vs 68Ga‑DOTATATE

A clear, patient‑friendly comparison

Both scans are excellent for finding neuroendocrine tumours (NETs). They work in the same basic way: a tracer attaches to somatostatin receptors on NET cells, and a PET/CT scanner shows where those cells are.

The differences mainly relate to image clarity, timing, and practical convenience.



🎯 What this means for patients

1. Image quality

64Cu‑DOTATATE often produces sharper, higher‑contrast images, especially for small lesions or areas with background activity (e.g., liver). 68Ga‑DOTATATE is still excellent, but the shorter half‑life means the tracer fades faster.

Why this matters: Sharper images can help your team see more detail, especially in complex cases.

2. Timing flexibility

Because 64Cu lasts longer in the body, imaging can be done over a wider time window. This reduces stress around exact timing and allows centres to run smoother schedules.  68Ga requires imaging quite soon after injection, which can feel more rushed.

3. Lesion detection

Studies show 64Cu‑DOTATATE can detect additional lesions that 68Ga or older SPECT scans may miss. This is especially true for:

  • very small lesions
  • liver metastases
  • unexpected metastatic sites

But both tracers are far superior to older octreotide scans.

4. Availability

68Ga‑DOTATATE is currently more widely available. 64Cu‑DOTATATE is expanding but not yet universal.

5. Radiation

Both scans use similar, safe levels of radiation. There is no meaningful difference for patients.

 

🌈 Bottom line for patients

  • Both scans are excellent for NET imaging.
  • 64Cu‑DOTATATE offers sharper images, more flexible timing, and may detect additional small lesions.
  • 68Ga‑DOTATATE is widely available, fast, and already a gold‑standard option.
  • Your care team will choose the tracer that is best for your situation and available locally.


References showing how 64Cu-Dotatate compares with other SSTR PET/CTs? Click the blue links to read.

1.  vs. 68Ga DOTATATE

There is a comparison of sorts between 64Cu Dotatate and 68Ga dotatate in this reference –

Choice Is Good at Times: The Emergence of [64Cu]Cu-DOTATATE–Based Somatostatin Receptor Imaging in the Era of [68Ga]Ga-DOTATATE | Journal of Nuclear Medicine (snmjournals.org)

2.  vs. 68Ga DOTATOC

Head-to-Head Comparison of 64Cu-DOTATATE and 68Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors | Journal of Nuclear Medicine (snmjournals.org)


Other Reads







Disclaimer

I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.

Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional.

Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.

Thanks for reading.

Ronny

 

Check out my WEGO Health Awards

Check out my Glossary of Terms – click here

 

Please Share this post for Neuroendocrine Cancer awareness and to help another patient



Discover more from Ronny Allan - Living with Neuroendocrine Cancer

Subscribe to get the latest posts sent to your email.

By Ronny Allan

Ronny Allan is a 3 x award-winning accredited patient leader advocating internationally for Neuroendocrine Cancer and all other cancer patients generally. Check out his Social Media accounts including Facebook, BlueSky, WhatsApp, Instagram and and X.

2 thoughts on “Detectnet™ (64Cu-DOTATATE) – an expansion of the Somatostatin Receptor PET Imaging for Neuroendocrine Cancer

I love comments - feel free!

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related Posts

Discover more from Ronny Allan - Living with Neuroendocrine Cancer

Subscribe now to keep reading and get access to the full archive.

Continue reading

Our website use cookies to improve and personalize your experience and to display advertisements(if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, Youtube. By using the website, you consent to the use of cookies. We have updated our Privacy Policy. Please click on the button to check our Privacy Policy.